Pappalardo Marco, Starnoni Marta, Franceschini Gianluca, Baccarani Alessio, De Santis Giorgio
Division of Plastic and Reconstructive Surgery, Department of Medical and Surgical Sciences, Modena Policlinico Hospital, University of Modena and Reggio Emilia, 41124 Modena, Italy.
Clinical and Experimental Medicine PhD Program, University of Modena and Reggio Emilia, 41124 Modena, Italy.
J Pers Med. 2021 May 12;11(5):402. doi: 10.3390/jpm11050402.
Breast cancer-related lymphedema (BCRL) represents a global healthcare issue affecting the emotional and life quality of breast cancer survivors significantly. The clinical presentation is characterized by swelling of the affected upper limb, that may be accompanied by atrophic skin findings, pain and recurrent cellulitis. Cardinal principles of lymphedema management are the use of complex decongestive therapy and patient education. Recently, new microsurgery procedures have been reported with interesting results, bringing in a new opportunity to care postmastectomy lymphedema. However, many aspects of the disease are still debated in the medical community, including clinical examination, imaging techniques, patient selection and proper treatment. Here we will review these aspects and the current literature.
乳腺癌相关淋巴水肿(BCRL)是一个全球性的医疗问题,严重影响乳腺癌幸存者的情绪和生活质量。临床表现为患侧上肢肿胀,可能伴有皮肤萎缩、疼痛和复发性蜂窝织炎。淋巴水肿管理的主要原则是采用综合消肿治疗和患者教育。最近,有报道称新的显微外科手术取得了有趣的结果,为乳房切除术后淋巴水肿的治疗带来了新机遇。然而,该疾病的许多方面在医学界仍存在争议,包括临床检查、成像技术、患者选择和恰当治疗。在此,我们将对这些方面及当前文献进行综述。